Editorial Board
The latest issue of the Annals of Oncology features its updated editorial board. This listing signifies the ongoing curation of expert oversight for one of the field’s premier journals, which publishes pivotal research on tumorigenesis, cancer genomics, and precision oncology. The board’s composition is critical for maintaining the journal’s rigorous peer-review standards, directly influencing the dissemination of high-impact findings in immuno-oncology, targeted therapies, and biomarker development.
Why it might matter to you: For professionals focused on the most important recent developments in oncology, understanding the gatekeepers of a leading journal provides context for the research landscape. It highlights the evolving expertise that shapes the literature on driver mutations, checkpoint inhibitors, and cancer biology you rely on. This knowledge can inform your evaluation of published studies and your strategic reading of the field.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
